Quercetin in Children With Fanconi Anemia; a Pilot Study

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 26, 2021

Study Completion Date

October 26, 2021

Conditions
Fanconi Anemia
Interventions
DRUG

Quercetin (dietary supplement)

"Quercetin will be given orally on a twice a day schedule starting with weight adjusted dose for a maximum total daily dose of 1500 mg/day, for 4 months (16 weeks). Pharmacokinetics (PK) data will be analyzed after each cohort of 3 patients and will be used to optimize the dosing schedule (if required)for subsequent patients.~An expansion cohort has been added to the study protocol. Up to 20 patients may be enrolled. The dose utilized will be the same as the max weight adjusted dose that showed biological activity in our last cohort of patients (subjects #10-12 from above)."

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT01720147 - Quercetin in Children With Fanconi Anemia; a Pilot Study | Biotech Hunter | Biotech Hunter